Skip to main content

Assembly Biosciences, Inc.

ASMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001426800

No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Assembly Biosciences, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of ASMB: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3245+13
Shares9.54M8.65M−890.5K (−9.3%)
Value$8.44M$7.09M−$1.35M (−16.0%)

New holders (17)

Institutions that held Assembly Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ASMB in Q4 2023
InstitutionSharesValue% of portfolio
Anson Funds Management LP719,470$590.0K0.12%
Acuitas Investments, LLC265,585$217.8K0.11%
Two Sigma Investments, LP135,048$110.8K0.00%
Amundi95,210$78.2K0.00%
Susquehanna International Group, LLP71,770$58.9K0.00%
Marquette Asset Management, LLC54,464$44.7K0.01%
Jane Street Group, LLC44,898$36.8K0.00%
HRT Financial LP30,518$25.0K0.00%
UBS Group AG24,164$19.8K0.00%
Tower Research Capital LLC (TRC)12,983$10.6K0.00%
Palumbo Wealth Management LLC10,075$8.26K0.00%
Clear Street Markets LLC5,000$4.00K0.00%
EverSource Wealth Advisors, LLC664$5450.00%
Bank of America Corp29$240.00%
Advisory Services Network, LLC1$10.00%
Royal Bank of Canada546$00.00%
Simplex Trading, LLC73$00.00%

Sold out (4)

Institutions that held Assembly Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ASMB in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Satter Management Co., L.P.2,227,500$1.97M
Hudson Bay Capital Management LP199,789$176.8K
Baker Avenue Asset Management, LP1,000$885
Advisor Group Holdings, Inc.500$443